[1]李楠,王严茹,李菲,等.螺内酯治疗甘草酸制剂致假性醛固酮增多症1例并文献综述[J].国际内分泌代谢杂志,2021,41(01):57-59.[doi:10.3760/cma.j.cn121383-20200302-03007]
　Li Nan,Wang Yanru,Li Fei,et al.Spironolactone in the treatment of glycyrrhizinic acid preparation-induced pseudoaldosteronism: a case report and literature review[J].International Journal of Endocrinology and Metabolism,2021,41(01):57-59.[doi:10.3760/cma.j.cn121383-20200302-03007]

点击复制

螺内酯治疗甘草酸制剂致假性醛固酮增多症1例并文献综述()

分享到：

参考文献/References:

[1] Takahashi K,Yoshino T,Maki Y,et al. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism:a multi-centre cross-sectional study[J].Arch Toxicol,2019,93(11):3111-3119.DOI:10.1007/s00204-019-02588-2.
[2] 高平进. Liddle综合征[M]//陈家伦. 临床内分泌学. 上海:上海科学技术出版社,2011:566-570.
[3] Armanini D,Karbowiak I,Funder JW. Affinity of licorice derivatives for mineralocorticoid and glucocorticoid receptors[J].Clin Endocrinol,1983,19(5):606-612.DOI:10.1111/j.1365-2265.1983.tb00038.x.
[4] Armanini D,Wehling M,Weber PC. Mineralocorticoid effector mechanism of licorice derivates in human mononuclear leukocytes[J].J Endocrinol Invest,1989,12(5):303-306.DOI:10.1007/BF03349993.
[5] Sabbadin C,Bordin L,Donà G,et al. Licorice:from pseudohyperaldosteronism to therapeutic uses[J].Front Endocrinol(Lausanne),2019,10:484.DOI:10.3389/fendo.2019.00484.
[6] Komatsu A,Yoshino T,Suzuki T,et al. Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis:a retrospective cohort study[J].Basic Clin Pharmacol Toxicol,2019,124(5):607-614.DOI:10.1111/bcpt.13178.
[7] orinaga O,Ishiuchi K,Ohkita T,et al. Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism[J].Sci Rep,2018,8(1):15568.DOI:10.1038/s41598-018-33834-9.
[8] Conn JW,Rovner DR,Cohen EL. Licorice-induced pseudoaldosteronism. Hypertension,hypokalemia,aldosteronopenia, and suppressed plasma renin activity[J].JAMA,1968,205(7):492-496.DOI:10.1001/jama.205.7.492.
[9] Karashima S,Yoneda T,Kometani M,et al. Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism[J].Hypertens Res,2016,39(3):133-137.DOI:10.1038/hr.2015.129.
[10] Carone L,Qxberry SG,Twycross R,et al. Spironolactone[J].J Pain Symptom Manage,2017,53(2):288-292.DOI:10.1016/j.jpainsymman.2016.12.320.
[11] Yoshino T,Yanagawa T,Watanabe K. Risk factors for pseudoaldosteronism with rhabdomyolysis caused by consumption of drugs containing licorice and differences between incidence of these conditions in Japan and other countries:case report and literature review[J].J Altern Complement Med,2014,20(6),516-520.DOI:10.1089/acm.2013.0454.
[12] Yang KQ,Xiao Y,Tian T,et al. Molecular genetics of Liddle's syndrome[J].Clin Chim Acta,2014,436,202-206.DOI:10.1016/j.cca.2014.05.015.